Fattah Shaimaa A, Elmadani Moshira, Abo-Elmatty Dina M, Awadallah Mohamed, Mehanna Eman T
Department of Biochemistry, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522 Egypt.
Forgery and Counterfeiting Researches Department, Forensic Medicine Authority, Minister of Justice, Ismailia, Egypt.
J Diabetes Metab Disord. 2022 Feb 24;21(1):557-565. doi: 10.1007/s40200-022-01008-0. eCollection 2022 Jun.
Diabetic peripheral neuropathy can injure the hand median nerve and cause extensive nerve damage. PKC and ALR are associated with progression of diabetic complications. We hypothesized a genetic association between the ALR polymorphisms (-106C → T/-12C → G) and elevated serum PKC-δ levels in diabetic neuropathy and its adverse effects on handwriting in Egyptian population.
One hundred DPN were compared with 100 DP and 100 healthy volunteers. ALR -106C → T/-12C → G variants were studied using the PCR-RFLP method. A routine set of standard laboratory markers was determined. Serum PKC-δ concentration was determined by ELISA. Logistic regression analysis and areas under the receiver characteristic curves (AUCs) were evaluated to investigate the predictors of diabetic neuropathy. Arabic handwriting was analyzed based on the recognition of functional features, word shape, and ascending/descending parts of letters.
Individuals carrying ALR-106C → C and -12G → G had a significantly higher risk of developing diabetic neuropathy than individuals with -106C → T and -12C → G genotypes ( = 0.01, = 0.02). Carriers of the (-106C → T) CC and (-12C → G) GG genotypes had significantly increased serum levels of PKC-δ, FBG, TC, and LDL-c. PKC- δ serum levels were significantly correlated with glycemic and lipid indicators ( < 0.001). PKC-δ is a significant predictor of diabetes with or without neuropathy at a cutoff value of 16.6, sensitivity was 89%, and specificity 100%. All DPN showed complete deterioration of handwriting after the onset of diabetic neuropathy.
The genetic variants ALR-106C → C / -12G → G and PKC-δ in serum may help in the detection and treatment of diabetic neuropathy in Egyptian population before writing performance is affected.
糖尿病周围神经病变可损伤手部正中神经并导致广泛的神经损伤。蛋白激酶C(PKC)和醛糖还原酶(ALR)与糖尿病并发症的进展有关。我们推测在埃及人群中,ALR基因多态性(-106C→T/-12C→G)与糖尿病神经病变中血清PKC-δ水平升高及其对手写能力的不良影响之间存在遗传关联。
将100例糖尿病周围神经病变患者与100例糖尿病患者及100名健康志愿者进行比较。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法研究ALR -106C→T/-12C→G变异。测定一组常规的标准实验室指标。采用酶联免疫吸附测定(ELISA)法测定血清PKC-δ浓度。采用逻辑回归分析和受试者特征曲线下面积(AUC)评估糖尿病神经病变的预测因素。基于对功能特征、单词形状和字母升降部分的识别,对阿拉伯语笔迹进行分析。
携带ALR-106C→C和-12G→G的个体患糖尿病神经病变的风险显著高于携带-106C→T和-12C→G基因型的个体(P = 0.01,P = 0.02)。(-106C→T)CC和(-12C→G)GG基因型携带者的血清PKC-δ、空腹血糖(FBG)、总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-c)水平显著升高。PKC-δ血清水平与血糖和血脂指标显著相关(P < 0.001)。PKC-δ是糖尿病伴或不伴神经病变的显著预测指标,截断值为16.6时,敏感性为89%,特异性为100%。所有糖尿病周围神经病变患者在糖尿病神经病变发作后笔迹均完全恶化。
血清中的ALR基因变异ALR-106C→C / -12G→G和PKC-δ可能有助于在埃及人群的书写能力受到影响之前检测和治疗糖尿病神经病变。